Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,615 | 35,290 | 27,610 | 38,102 | 37,082 |
| Marketable Securities | 87,647 | 17,540 | 31,230 | 48,684 | 40,542 |
| Receivables | 3,346 | 5,420 | 3,460 | 0 | 0 |
| Other current assets | 2,596 | 940 | 880 | 2,364 | 1,732 |
| TOTAL | $133,204 | $59,190 | $63,180 | $89,150 | $79,356 |
| Non-Current Assets | |||||
| PPE Net | 22,625 | 23,940 | 21,540 | 18,785 | 15,334 |
| Investments And Advances | 12,491 | 6,990 | 0 | 0 | 0 |
| Intangibles | 14,315 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 621 | 12,970 | 11,340 | 9,946 | 6,615 |
| TOTAL | $50,052 | $43,900 | $32,880 | $28,731 | $21,949 |
| Total Assets | $183,256 | $103,100 | $96,070 | $117,881 | $101,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,607 | 3,890 | 3,580 | 2,252 | 6,238 |
| Accounts payable and accrued liabilities | 2,231 | 3,140 | 2,970 | 2,843 | 2,362 |
| Accrued Expenses | 5,027 | 3,770 | 5,800 | 6,589 | 4,252 |
| Other current liabilities | N/A | 4,160 | 10,170 | 14,893 | 10,204 |
| TOTAL | $14,636 | $14,980 | $22,530 | $26,577 | $23,056 |
| Non-Current Liabilities | |||||
| Long Term Debt | 102,254 | 87,250 | 77,720 | 56,452 | 19,864 |
| Deferred Revenues | 2,771 | N/A | N/A | N/A | N/A |
| TOTAL | $102,254 | $87,250 | $77,720 | $56,452 | $19,864 |
| Total Liabilities | $116,890 | $102,230 | $100,260 | $83,029 | $42,920 |
| Shareholders' Equity | |||||
| Common Shares | 40 | 30 | 20 | 27 | 26 |
| Retained earnings | -311,460 | -256,760 | -197,110 | -154,133 | -123,067 |
| Other shareholders' equity | 23,298 | 12,400 | 180 | 165 | 178 |
| TOTAL | $66,366 | $860 | $-4,180 | $34,852 | $58,385 |
| Total Liabilities And Equity | $183,256 | $103,090 | $96,080 | $117,881 | $101,305 |